Anne Marie Falk

Array ( [id] => 7281237 [patent_doc_number] => 20040063614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Brain-protective agent' [patent_app_type] => new [patent_app_number] => 10/677301 [patent_app_country] => US [patent_app_date] => 2003-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2346 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063614.pdf [firstpage_image] =>[orig_patent_app_number] => 10677301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6990834 [patent_doc_number] => 20050089871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'G protein-related kinase mutants in essential hypertension' [patent_app_type] => utility [patent_app_number] => 10/677983 [patent_app_country] => US [patent_app_date] => 2003-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13989 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089871.pdf [firstpage_image] =>[orig_patent_app_number] => 10677983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7280824 [patent_doc_number] => 20040063201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture, methods for assaying the effect of substances of lineage-specific cell production, and cell compositions produced by these cultures' [patent_app_type] => new [patent_app_number] => 10/668179 [patent_app_country] => US [patent_app_date] => 2003-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23912 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063201.pdf [firstpage_image] =>[orig_patent_app_number] => 10668179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7419286 [patent_doc_number] => 20040228881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Compositions and methods for modulating neural sprouting' [patent_app_type] => new [patent_app_number] => 10/667998 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6294 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228881.pdf [firstpage_image] =>[orig_patent_app_number] => 10667998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7208537 [patent_doc_number] => 20050053586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Entrapped stem cells and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/655275 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3959 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053586.pdf [firstpage_image] =>[orig_patent_app_number] => 10655275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4574813 [patent_doc_number] => 07825097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-02 [patent_title] => 'Nucleotide vector vaccine for immunization against hepatitis' [patent_app_type] => utility [patent_app_number] => 10/644267 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 23 [patent_no_of_words] => 5887 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/825/07825097.pdf [firstpage_image] =>[orig_patent_app_number] => 10644267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206816 [patent_doc_number] => 20040087535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Pharmaceutical composition for angiogenesis' [patent_app_type] => new [patent_app_number] => 10/636901 [patent_app_country] => US [patent_app_date] => 2003-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6679 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087535.pdf [firstpage_image] =>[orig_patent_app_number] => 10636901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7355864 [patent_doc_number] => 20040013650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Long term expression of gene products' [patent_app_type] => new [patent_app_number] => 10/615518 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8197 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013650.pdf [firstpage_image] =>[orig_patent_app_number] => 10615518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7226954 [patent_doc_number] => 20040073018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Human methionine synthase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer' [patent_app_type] => new [patent_app_number] => 10/607712 [patent_app_country] => US [patent_app_date] => 2003-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12299 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20040073018.pdf [firstpage_image] =>[orig_patent_app_number] => 10607712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7036726 [patent_doc_number] => 20050034185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-10 [patent_title] => 'Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight' [patent_app_type] => utility [patent_app_number] => 10/603249 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 21500 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20050034185.pdf [firstpage_image] =>[orig_patent_app_number] => 10603249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5851182 [patent_doc_number] => 20060234373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Treatment for diabetes' [patent_app_type] => utility [patent_app_number] => 10/515772 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 13357 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234373.pdf [firstpage_image] =>[orig_patent_app_number] => 10515772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474623 [patent_doc_number] => 20040055028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Urocortin-deficient mice and uses thereof' [patent_app_type] => new [patent_app_number] => 10/440636 [patent_app_country] => US [patent_app_date] => 2003-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9200 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20040055028.pdf [firstpage_image] =>[orig_patent_app_number] => 10440636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7369525 [patent_doc_number] => 20040016010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'IL-21 receptor knockout animal and methods of use thereof' [patent_app_type] => new [patent_app_number] => 10/418450 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15283 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20040016010.pdf [firstpage_image] =>[orig_patent_app_number] => 10418450 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7392808 [patent_doc_number] => 20040083498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-29 [patent_title] => 'Cloning method using oocytes matured in vivo' [patent_app_type] => new [patent_app_number] => 10/414458 [patent_app_country] => US [patent_app_date] => 2003-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8974 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20040083498.pdf [firstpage_image] =>[orig_patent_app_number] => 10414458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 425330 [patent_doc_number] => 07271313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Presenilin-deficient mouse model of age-dependent neurodegeneration and cognitive loss' [patent_app_type] => utility [patent_app_number] => 10/409672 [patent_app_country] => US [patent_app_date] => 2003-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10353 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 351 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/271/07271313.pdf [firstpage_image] =>[orig_patent_app_number] => 10409672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701531 [patent_doc_number] => 20030224411 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Genes that are up- or down-regulated during differentiation of human embryonic stem cells' [patent_app_type] => new [patent_app_number] => 10/388578 [patent_app_country] => US [patent_app_date] => 2003-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 28959 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224411.pdf [firstpage_image] =>[orig_patent_app_number] => 10388578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769492 [patent_doc_number] => 20030215432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues' [patent_app_type] => new [patent_app_number] => 10/386144 [patent_app_country] => US [patent_app_date] => 2003-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10713 [patent_no_of_claims] => 110 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215432.pdf [firstpage_image] =>[orig_patent_app_number] => 10386144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7373184 [patent_doc_number] => 20040006782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Non-human mammal mutant for expression of the alpha6 subunit of the nicotinic acetylcholine receptor, and use for screening substances that can interact with said receptor' [patent_app_type] => new [patent_app_number] => 10/377614 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 9263 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20040006782.pdf [firstpage_image] =>[orig_patent_app_number] => 10377614 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474617 [patent_doc_number] => 20040055026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Neurological disease model' [patent_app_type] => new [patent_app_number] => 10/379343 [patent_app_country] => US [patent_app_date] => 2003-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6046 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20040055026.pdf [firstpage_image] =>[orig_patent_app_number] => 10379343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701092 [patent_doc_number] => 20030223972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells' [patent_app_type] => new [patent_app_number] => 10/368810 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10401 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20030223972.pdf [firstpage_image] =>[orig_patent_app_number] => 10368810 [rel_patent_id] =>[rel_patent_doc_number] =>)